Onychodystrophy: Difference between revisions
No edit summary |
|||
| Line 15: | Line 15: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
== Overview == | == Overview == | ||
Revision as of 14:33, 6 August 2012
| Onychodystrophy | |
 | |
|---|---|
| ICD-10 | L60 |
| ICD-9 | 703.8 |
| MedlinePlus | 003247 |
|
WikiDoc Resources for Onychodystrophy |
|
Articles |
|---|
|
Most recent articles on Onychodystrophy Most cited articles on Onychodystrophy |
|
Media |
|
Powerpoint slides on Onychodystrophy |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Onychodystrophy at Clinical Trials.gov Trial results on Onychodystrophy Clinical Trials on Onychodystrophy at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Onychodystrophy NICE Guidance on Onychodystrophy
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Onychodystrophy Discussion groups on Onychodystrophy Patient Handouts on Onychodystrophy Directions to Hospitals Treating Onychodystrophy Risk calculators and risk factors for Onychodystrophy
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Onychodystrophy |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Onychodystrophy is a deformation of the nails that can result from cancer chemotherapy which includes bleomycin, hydroxyurea, or 5-fluorouracil. It can include discoloration of the nail, or dyschromia.